Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Taymaa May, M.D.

Concepts (247)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms56202448757.080 Why?
Cystadenocarcinoma, Serous1920244756.580 Why?
Neoadjuvant Therapy18202428112.560 Why?
Indocyanine Green320242362.120 Why?
CA-125 Antigen420242801.930 Why?
Chemotherapy, Adjuvant16202435311.920 Why?
Genital Neoplasms, Female720245381.900 Why?
Fluorescein Angiography3202410451.660 Why?
Anastomosis, Surgical220249831.290 Why?
Gynecologic Surgical Procedures420243061.250 Why?
Neoplasms, Glandular and Epithelial520224871.230 Why?
Fallopian Tube Neoplasms520223290.960 Why?
Endometrial Neoplasms9202213610.950 Why?
Neoplasm Staging192024111410.910 Why?
Uterine Cervical Neoplasms6202420180.900 Why?
Carcinoma6202223340.850 Why?
Digestive System Surgical Procedures320215760.760 Why?
Hospitals, Private12021630.740 Why?
Hysterectomy620219010.690 Why?
Hospitals, Public120212010.680 Why?
BRCA1 Protein5202411460.650 Why?
Laparoscopy3202121550.630 Why?
Cisplatin2202116420.610 Why?
Canada9202221280.600 Why?
Adnexal Diseases120191040.600 Why?
Retrospective Studies362024803010.590 Why?
Genes, BRCA2220186040.570 Why?
Ovary120219590.560 Why?
Genes, BRCA1220187690.550 Why?
Female8420243910110.540 Why?
Rhabdomyosarcoma120183610.510 Why?
Lymph Node Excision3202113050.500 Why?
Choriocarcinoma220131210.470 Why?
Laparotomy120174680.470 Why?
Antineoplastic Agents42021136290.460 Why?
Hematologic Diseases120184970.450 Why?
Germ-Line Mutation2202118430.440 Why?
BRCA2 Protein420247970.430 Why?
Mixed Tumor, Mullerian12012550.420 Why?
Neoplasm Recurrence, Local9202492740.420 Why?
Alcohol Oxidoreductases120131690.410 Why?
Intestines1202119070.400 Why?
Middle Aged3920242201750.380 Why?
Cohort Studies162024413170.370 Why?
Humans8220247602610.360 Why?
Injections, Intraperitoneal220214130.360 Why?
Sinus Thrombosis, Intracranial120111100.350 Why?
Antineoplastic Combined Chemotherapy Protocols72024117080.330 Why?
Organoplatinum Compounds320204100.330 Why?
Carcinoma, Papillary220147850.310 Why?
Aged2920241689950.310 Why?
Adult3120242198470.280 Why?
Neoplasm, Residual3202310080.280 Why?
Uterine Neoplasms2201314340.260 Why?
Aged, 80 and over152024589470.250 Why?
Sentinel Lymph Node Biopsy220217270.240 Why?
Kaplan-Meier Estimate4202365450.230 Why?
Ileostomy120241190.230 Why?
Coloring Agents120245610.200 Why?
Genome-Wide Association Study72024126020.200 Why?
Neurofibrosarcoma12021260.190 Why?
Urinary Retention120221070.190 Why?
Young Adult102024586730.180 Why?
Fallopian Tubes420221780.180 Why?
Nerve Tissue Proteins1201344090.180 Why?
Carcinoma, Endometrioid220142760.180 Why?
Genetic Predisposition to Disease92024177660.170 Why?
Epigenesis, Genetic1201337580.170 Why?
Poly(ADP-ribose) Polymerases220134280.170 Why?
Vaginal Neoplasms120201050.170 Why?
Ontario420214050.160 Why?
Glucuronosyltransferase120191300.160 Why?
Survival Rate52021128060.150 Why?
Tumor Burden2202118970.150 Why?
Cancer Care Facilities120214250.150 Why?
Gynecology220215340.150 Why?
Endometrium120204030.150 Why?
Vulvar Neoplasms120202650.140 Why?
Carcinoma, Adenosquamous12017660.140 Why?
Drug Administration Schedule3202049000.140 Why?
Gene Expression Regulation, Neoplastic1201384980.140 Why?
Markov Chains120209710.140 Why?
Peritoneal Neoplasms120237060.140 Why?
Polymorphism, Single Nucleotide82024157660.140 Why?
Inheritance Patterns120193400.140 Why?
Receptors, Calcitriol120193590.140 Why?
Intracellular Signaling Peptides and Proteins2202128740.130 Why?
Models, Economic120207190.130 Why?
Intraoperative Care120207680.130 Why?
Survival Analysis32024101850.130 Why?
Urinary Tract Infections120228170.130 Why?
Pelvis220177430.130 Why?
Postoperative Care1202114780.120 Why?
Endometriosis220148710.120 Why?
Quality Improvement5202438400.120 Why?
Mutation62024299500.120 Why?
Communicable Disease Control120218440.120 Why?
Radiotherapy1202115050.120 Why?
Adenocarcinoma3201763100.120 Why?
Triage120219820.110 Why?
Proportional Hazards Models22018125320.110 Why?
Cell Line, Tumor32021169050.110 Why?
Vaginal Smears120164950.110 Why?
Antineoplastic Agents, Hormonal1202115230.110 Why?
Co-Repressor Proteins120131910.100 Why?
Patient Discharge2202434750.100 Why?
Lymphocytes1202026120.100 Why?
MutS Homolog 2 Protein120121950.100 Why?
Adenocarcinoma, Clear Cell120142180.100 Why?
Neoplasms, Multiple Primary220145860.100 Why?
Myometrium120121760.100 Why?
Pain, Postoperative1202117180.090 Why?
Pregnancy Complications, Neoplastic120132550.090 Why?
Methionine120135690.090 Why?
Disease Models, Animal22021181340.090 Why?
Phthalazines120133770.090 Why?
Decision Support Techniques1202020020.090 Why?
Preoperative Care1201922550.090 Why?
Brain Neoplasms1201189840.080 Why?
Cyclin-Dependent Kinase 2120101830.080 Why?
Medical Oncology1202123210.080 Why?
Time Factors32021401330.080 Why?
Combined Modality Therapy2202185510.080 Why?
Sensitivity and Specificity32021146560.080 Why?
Gene Knockdown Techniques1201316170.080 Why?
Glucocorticoids1201821430.080 Why?
Gene Expression Profiling3201893880.080 Why?
Genetic Testing1202135300.070 Why?
Neutrophils1202037700.070 Why?
Genetic Loci1201726180.070 Why?
Cost-Benefit Analysis1202055070.070 Why?
Patient Care Team1201825100.070 Why?
Membrane Proteins1202478540.070 Why?
Wound Healing1201827860.070 Why?
Prospective Studies52023542630.060 Why?
Analgesics, Opioid1202137620.060 Why?
Postoperative Complications42024156800.060 Why?
Disease Progression12021135050.060 Why?
Apoptosis Regulatory Proteins1201011350.060 Why?
DNA Methylation1201843740.060 Why?
Head and Neck Neoplasms1201928800.060 Why?
Latent TGF-beta Binding Proteins12024430.060 Why?
Multivariate Analysis12017121560.060 Why?
Cell Survival1201357960.050 Why?
Risk Factors82024742690.050 Why?
Breast Neoplasms22022210650.050 Why?
Practice Guidelines as Topic2202174680.050 Why?
Reverse Transcriptase Polymerase Chain Reaction1201045730.050 Why?
Piperazines1201325200.050 Why?
High-Throughput Nucleotide Sequencing1201536180.050 Why?
Bayes Theorem2202223250.050 Why?
Promoter Regions, Genetic1201357840.050 Why?
Carcinoma, Squamous Cell1201740240.050 Why?
Melanoma1202056950.050 Why?
Quantitative Trait Loci2202021010.050 Why?
Urinary Catheterization120222000.050 Why?
Lymphatic Metastasis2202129450.050 Why?
Neoplasm Seeding12021850.050 Why?
Pandemics1202186210.050 Why?
Urination120222020.050 Why?
Phosphoproteins1201024410.050 Why?
Mitogen-Activated Protein Kinase Kinases120236420.050 Why?
Fibrinogen120248870.040 Why?
Infusions, Parenteral120204040.040 Why?
Vulva12020820.040 Why?
Chemotherapy, Cancer, Regional Perfusion12020920.040 Why?
Predictive Value of Tests32021152730.040 Why?
Adaptor Proteins, Signal Transducing1201028950.040 Why?
Body Mass Index12017129010.040 Why?
Colorectal Neoplasms1201968550.040 Why?
Alleles2202269000.040 Why?
Gene Knockout Techniques120218030.040 Why?
Area Under Curve1202216350.040 Why?
Preoperative Period120205550.040 Why?
Carboplatin120217890.040 Why?
Randomized Controlled Trials as Topic32020103400.040 Why?
Prognosis42021296360.040 Why?
Adolescent32021877470.040 Why?
Oncogenes1202312210.040 Why?
Case-Control Studies32024220410.040 Why?
Mice22021812160.040 Why?
Perioperative Period120182650.030 Why?
Mass Spectrometry1202421920.030 Why?
Animals420211679400.030 Why?
Hyperthermia, Induced120204150.030 Why?
Telomere-Binding Proteins120171190.030 Why?
Immunohistochemistry12010110640.030 Why?
Glycoproteins1202422080.030 Why?
Receptors, Glucocorticoid120182960.030 Why?
United States22021723630.030 Why?
Child, Preschool12018420340.030 Why?
Prostatic Neoplasms12019113410.030 Why?
Diagnosis, Differential12011129680.030 Why?
Tomography, X-Ray Computed12019204840.030 Why?
Postoperative Period1202018210.030 Why?
Treatment Outcome32018649470.030 Why?
Hong Kong120151610.030 Why?
Morbidity1202017650.030 Why?
SEER Program1202015320.030 Why?
Vagina120208420.030 Why?
Lung Neoplasms12019132490.030 Why?
Taxoids120176680.030 Why?
Incidental Findings120196980.030 Why?
DNA Copy Number Variations1202220080.030 Why?
Paclitaxel1202117380.030 Why?
Genotype22018129590.030 Why?
Pregnancy22013297250.030 Why?
Hydrops Fetalis120131090.030 Why?
MAP Kinase Signaling System1202014830.030 Why?
Term Birth120131400.030 Why?
Algorithms22023139670.030 Why?
Meta-Analysis as Topic1201713750.020 Why?
Neoplasm Invasiveness1202036180.020 Why?
Histocytochemistry120126930.020 Why?
Chorionic Gonadotropin120134570.020 Why?
New England1201310450.020 Why?
Stillbirth120133650.020 Why?
Disease-Free Survival1202068300.020 Why?
Live Birth120135120.020 Why?
Genetic Association Studies1201927160.020 Why?
Quality of Life22021133000.020 Why?
Women's Health1201820570.020 Why?
Patient Selection1202142760.020 Why?
Papillomaviridae1201511170.020 Why?
Models, Genetic1201834420.020 Why?
Biopsy1202067750.020 Why?
Neoplasm Metastasis1201948910.020 Why?
Length of Stay1202264720.020 Why?
Genomics1202457900.020 Why?
Neoplasm Proteins1201936130.020 Why?
Risk1201896290.020 Why?
Heterozygote1201227970.020 Why?
Lymph Nodes1201734910.020 Why?
Academic Medical Centers1201627530.020 Why?
Vitamin D1201932930.020 Why?
Logistic Models12019133110.010 Why?
Drug Resistance, Neoplasm1201852300.010 Why?
Massachusetts1201688050.010 Why?
Smoking1201990700.010 Why?
Phenotype12019165430.010 Why?
Follow-Up Studies12021392540.010 Why?
Mass Screening1201654220.010 Why?
Mice, Inbred C57BL12018220250.010 Why?
Mental Disorders1201967970.010 Why?
Risk Assessment12020240860.010 Why?
Child12020797580.010 Why?
Male120193594130.000 Why?
May's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (247)
Explore
_
Co-Authors (38)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.